The IDH+ TIME appeared to be more immunogenically ‘cold’, with a lower frequency of microsatellite instability (MSI), high tumour mutation burden (TMB) (more than 10 mutations per mega base) and high PD-L1 expression in the population [55]. The gene discussed is IDH1; the disease is neoplasm.